ALS Center Research Program
ALS research at Wake Forest is divided into 2 equal parts that work together to test promising therapies and develop new ideas about the cause of ALS which generate novel treatments.
WFSM ALS Clinical Research Unit
The Clinical Research Unit provides patients with the opportunity to receive the latest experimental therapies and to supply information and biological samples that will further our understanding of ALS.
James Caress, MD, directs the ALS Center and has over 15 years of experience helping patients fight ALS. He has participated in over 20 clinical trials and other research projects designed to treat or understand ALS.
[Dr. Caress discusses ALS Research at Wake Forest Baptist Health.]
Michael Cartwright, MD, MPH, completed a 2-year MDA-sponsored fellowship to study ALS and other neuromuscular diseases.
Mozdeh Marandi, MD, coordinates most of the clinical research effort at the ALS Center.
WFSM ALS Translational Science Unit
The Translational Science Unit (TSU) aims to illuminate the cause and progression of ALS and to test novel therapies that can slow the progression of the disease. The TSU recently received a major grant to study the process of the nerves disconnecting from the muscles at the earliest stages of ALS. Learning about this process may lead to new ideas about how to keep these connections intact.
[Review a video describing translational research in ALS at Wake Forest Baptist Health.]